Position in VTRS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$862,347
+$153,806 QoQ
Shares Held
54,304
-4.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#330
of 1,016 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SS&H Financial Advisors, Inc. holds $1,099,485 across 2 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (78.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
54,304 | $862,347 | |
| 2 | ZTS |
Zoetis Inc.
|
3,300 | $237,138 |
All Filings in VTRS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $862,347 | 54,304 | Shares | Sole | 2026-08-04 | |
| 2025-12-31 | $708,541 | 56,911 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $573,794 | 57,959 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $539,309 | 60,393 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $528,426 | 60,669 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $803,996 | 64,578 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $940,781 | 81,032 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $908,854 | 85,499 | Shares | Sole | 2024-09-10 | |
| 2024-03-31 | $102 | 85,785 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $954,989 | 88,180 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $878,664 | 89,114 | Shares | Sole | 2023-10-18 | |
| 2023-03-31 | $825,482 | 85,809 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $982,066 | 88,236 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $761,134 | 89,335 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $899,467 | 85,909 | Shares | Sole | 2022-07-14 | |
| No filing history on record for this holder in this stock. | ||||||